Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The recent development of propofol (DIPRIVAN).

× No keyword cloud information.

13 in total

1. Propofol Use in Pediatric Patients With Food Allergy and Eosinophilic Esophagitis.

Authors: Pooja Mehta; Shikha S Sundaram; Glenn T Furuta; Zhaoxing Pan; Dan Atkins; Scott Markowitz
Journal: J Pediatr Gastroenterol Nutr Date: 2017-04 Impact factor: 2.839

Review 2. Propofol: a review of its role in pediatric anesthesia and sedation.

Authors: Vidya Chidambaran; Andrew Costandi; Ajay D'Mello
Journal: CNS Drugs Date: 2015-07 Impact factor: 5.749

Review 3. Propofol: a review of its use in intensive care sedation of adults.

Authors: Kate McKeage; Caroline M Perry
Journal: CNS Drugs Date: 2003 Impact factor: 5.749

4. Preparation and evaluation of novel mixed micelles as nanocarriers for intravenous delivery of propofol.

Authors: Xinru Li; Yanhui Zhang; Yating Fan; Yanxia Zhou; Xiaoning Wang; Chao Fan; Yan Liu; Qiang Zhang
Journal: Nanoscale Res Lett Date: 2011-03-31 Impact factor: 4.703

5. The application of EDTA in drug delivery systems: doxorubicin liposomes loaded via NH4EDTA gradient.

Authors: Yanzhi Song; Zhenjun Huang; Yang Song; Qingjing Tian; Xinrong Liu; Zhennan She; Jiao Jiao; Eliza Lu; Yihui Deng
Journal: Int J Nanomedicine Date: 2014-08-01

Review 6. Nanoparticles in the clinic.

Authors: Aaron C Anselmo; Samir Mitragotri
Journal: Bioeng Transl Med Date: 2016-06-03

7. The effect of implementing an aseptic practice bundle for anaesthetists to reduce postoperative infections, the Anaesthetists Be Cleaner (ABC) study: protocol for a stepped wedge, cluster randomised, multi-site trial.

Authors: Alan F Merry; Derryn A Gargiulo; Ian Bissett; David Cumin; Kerry English; Christopher Frampton; Richard Hamblin; Jacqueline Hannam; Matthew Moore; Papaarangi Reid; Sally Roberts; Elsa Taylor; Simon J Mitchell
Journal: Trials Date: 2019-06-10 Impact factor: 2.279

The recent development of propofol (DIPRIVAN).